Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 19
- Industry Trends
Germany Medical Cannabis Imports Surge a Further 19%, but Are Looming Curbs Actually Boosting Demand?
Germany’s medical cannabis imports continued their historic run in Q3 of 2025, seeing the country bring in just under 57 tonnes, though growth levels dipped slightly from Q2.
- Industry Trends
Is Portugal About to Lose its Position as the ‘Gateway’ to Europe’s Largest Cannabis Markets?
Over the last five years, Portugal has built a reputation as the medical cannabis ‘doorway to Europe’, the go-to hub for countries from North and South America, Asia and Oceania to ship their cannabis to and have it distributed to Europe’s most active markets.
- Events
Business of Cannabis: New York 2025 – Key Takeaways
Business of Cannabis: New York 2025 arrived at a crucial moment not just for the local cannabis industry, but for the entire state.
- Medical Cannabis
Curaleaf Laboratories Enters Strategic Partnership with ANTG to Manufacture and Distribute Medicinal Cannabis Products in the UK
Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers of pharmaceutical-grade medicinal cannabis.
- Medical Cannabis
SOMAÍ Adds International Lifestyle Brand Cookies to Global Medical Cannabis Markets
Cookies, the most globally recognised cannabis brand, is entering global medical markets with a full extract portfolio through a strategic partnership with SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO).
- Hemp Industry
Plans to Ban Intoxicating Hemp Take Center Stage in Battle to Reopen US Government
The long-running battle over the future of the US hemp industry has become an unlikely flashpoint in efforts to end the longest government shutdown in history.
- Industry Trends
Why Cannabis Stocks Are So Volatile: How Policy, Capital and Hype Shaped a Perpetual Rollercoaster
From the euphoric highs of 2018’s ‘green rush’ to the sharp corrections and structural stasis that have followed, cannabis equities have been among the most volatile financial assets since they first appeared on global markets.
- Medical Cannabis
Cannabis Group Cannim Collapses: UK Clinics Pause, Creditors Pursue Millions
Cannim Group Pty, the international medical cannabis company with operations spanning the UK, Australia, the US and Canada, has entered voluntary administration.
- Industry Trends
New Data Shows UK Medical Cannabis Industry Still Has a Gender Problem
Despite being the second-largest and one of the most mature medical cannabis markets in Europe, the UK still falls well behind its peers in one key area, data.
- Industry Trends
Why is No One Talking About Germany’s Oversupply Problem?
Germany’s telemedicine-fuelled expansion has driven the value of its medical cannabis market up by hundreds of millions of euros in just less than two years.
- Prescribers & Clinics
High-THC Leads Growth as Australia Tightens TGA Prescribing Rules
The medical cannabis industries in Australia and New Zealand are continuing to evolve rapidly, with both markets showing signs of maturation, regulatory recalibration, and expanding export ambitions, according to new data.
- Hemp Industry
What the US Government Shutdown Means for Cannabis Reform
President Donald Trump has called on Senate Republicans to invoke the so-called ‘nuclear option’ to break the month-long government shutdown, a move that would eliminate the long-standing 60-vote filibuster rule and allow other legislation to pass by a simple majority.
